Cargando…
Dual Kinase Targeting in Leukemia
SIMPLE SUMMARY: A new option to treat cancer is based on the use of so-called multi-targeting drugs. This strategy can replace the standard treatment based on the co-administration of several drugs. An increased and uncontrolled activity of kinases (enzymes devoted to the regulation of several cell...
Autores principales: | Mologni, Luca, Marzaro, Giovanni, Redaelli, Sara, Zambon, Alfonso |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796318/ https://www.ncbi.nlm.nih.gov/pubmed/33401428 http://dx.doi.org/10.3390/cancers13010119 |
Ejemplares similares
-
Discovery of Novel α-Carboline Inhibitors
of the Anaplastic Lymphoma Kinase
por: Mologni, Luca, et al.
Publicado: (2022) -
Proteolysis Targeting Chimeric Molecules: Tuning Molecular Strategies for a Clinically Sound Listening
por: Pedrucci, Federica, et al.
Publicado: (2022) -
New Advances in Liquid Biopsy Technologies for Anaplastic Lymphoma Kinase (ALK)—Positive Cancer
por: Villa, Matteo, et al.
Publicado: (2021) -
Targeting kinases with anilinopyrimidines: discovery of N-phenyl-N’-[4-(pyrimidin-4-ylamino)phenyl]urea derivatives as selective inhibitors of class III receptor tyrosine kinase subfamily
por: Gandin, Valentina, et al.
Publicado: (2015) -
Mitochondrial Hyperactivation and Enhanced ROS Production are Involved in Toxicity Induced by Oncogenic Kinases Over-Signaling
por: Ceccon, Monica, et al.
Publicado: (2018)